Persistently activated PI3K/Akt/mTOR signalling in tumours reduces ubiquitination and degradation of Cyclin D, promotes synthesis and assembly of Cyclin D‐related proteins, and increases expression of the Cyclin D‐CDK4/6 complex [64]. The gene discussed is MTOR; the disease is neoplasm.